[1] Russell AH,Clyde C,Wasserman TH. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastasis: results of the RTOG dose-escalating protocol. Int J Radiat Oncol Biol Phys,1993,27:117-123. [2] Emami B,Lyman J,Brown A,et al. Tolerance of normal tissue to the therapeutic irradiation. Int J Radiat Oncol Biol Phys,1991,21:109-122. [3] 杨秉辉,夏景林. 原发性肝癌的临床诊断与分期标准.中华肝脏病杂志,2001,9:324. [4] Cheng JC,Wu JK,Huang CM,et al. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. Int J Radiat Oncol Biol Phys,2002,54:156-162. [5] Park HC,Seong J,Han KH,et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys,2002,54:150-155. [6] Dawson LA,McGinn CJ,Normolle D,et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol,2000,18:2210-2218. [7] 李家敏,刘素文,蔡伟明,等.复发性鼻咽癌X线调强放疗和质子治疗剂量学研究.中华放射肿瘤学杂志,2007,16:152-153. [8] 李家敏,于金明,刘素文,等.质子束在肝细胞肝癌治疗中的剂量分布—与X线三维适形及调强放射治疗计划对比. 中华医学杂志,2009,89:3201-3206. [9] Guo WJ,Yu EX,Liu LM,et al. Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma. World J Gastroenterol,2003,9:1697-1701. [10] Seong J,Shim SJ,Lee IJ,et al. Evaluation of the prognostic value of Okuda,cancer of the liver Italian program,and Japan integrated staging systems for hepatocellular carcinoma patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys,2007,67:1037-1042. [11] Liu MT,Li SH,Chu TC,et al. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol,2004,34:532-539.
2012, Vol. 21 
